Transcriptomic biomarkers, method of determination and application of transcriptomic biomarkers for the stratification of the individual risk of development of the post-heart failure cardiac insufficiency

摘要

The invention consists of transcrypto biomarkers to stratify the individual risk of developing non-verbal heart failure corresponding to an increased level of expression of at least two genes from a group of transcripts comprising: FNM1, RNASE1, TIMP1, JDP2, or at least one genus from a group of transcripts comprising: FMN1, RNASE1, JDP2.